Filing search / Fate Therapeutics, Inc. / "Chronic"

8-K

EX-99.1

FATE Fate Therapeutics, Inc.

9 May 24

Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

4:02pm

clinical development exclusively in autoimmunity. 43 heavily pre-treated patients (B cell lymphoma, n=25; chronic lymphocytic leukemia, n=12; and acute

8-K

FATE Fate Therapeutics, Inc.

9 May 24

Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program

9:01am

exclusively in the field of autoimmune diseases. 43 heavily pre-treated patients (B cell lymphoma, n=25; chronic lymphocytic leukemia, n=12; and acute

424B5

FATE Fate Therapeutics, Inc.

20 Mar 24

Prospectus supplement for primary offering

5:30pm

Preclinical CAR T-cell Programs FT819 B-cell Lymphoma CD19 Phase 1 Chronic Lymphocytic Leukemia CD19 Phase 1 Systemic Lupus Erythematosus CD19 Phase 1

8-K

EX-99.1

ab13bopa8b9 7acls46v

8 Nov 23

Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates

4:03pm

8-K

EX-99.1

xxnosjqm0izkzu8cu29w

8 Aug 23

Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates

4:07pm

8-K

EX-99.1

vkc p7s3yq0a

3 May 23

Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates

4:06pm

8-K

EX-99.1

dqbi1dpdudn

3 Nov 22

Fate Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Operational Progress

4:03pm

8-K

EX-99.1

5t5jq

3 Aug 22

Fate Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Operational Progress

4:03pm

8-K

EX-99.1

v4ah6axrnornerc31y

4 May 22

Fate Therapeutics Reports First Quarter 2022 Financial Results and Highlights Operational Progress

4:06pm

8-K

EX-99.1

s3vyewy 76ww

28 Feb 22

Fate Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Operational Progress

4:06pm

8-K

EX-99.2

zbmgslwto6v1wocnc

14 Dec 21

Other Events

5:28pm

8-K

EX-99.1

by8oz aqw

4 Nov 21

Fate Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Operational Progress

4:07pm

8-K

EX-99.1

0vvw39v c6guc

4 Aug 21

Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress

4:05pm

8-K

EX-99.1

t5aru197vcdgbu gv

5 May 21

Fate Therapeutics Reports First Quarter 2021 Financial Results and Highlights Operational Progress

4:01pm

8-K

EX-99.1

6dh60ge8w o5m

24 Feb 21

Fate Therapeutics Reports Fourth Quarter 2020 Financial Results and Highlights Operational Progress

4:01pm